close

Topic

Created by tristan on 4/10/2007

Asenapine ^en

mid: /m/0264jhb notable type: /medicine/drug notable for: /medicine/drug on the web: wikipedia.org

Asenapine is an atypical antipsychotic developed for the treatment of schizophrenia and acute mania associated with bipolar disorder by Schering-Plough after its November 19, 2007 merger with Organon International. Development of the drug, through Phase III trials, began while Organon was still a part of Akzo Nobel. Preliminary data indicate that it has minimal anticholinergic and cardiovascular side effects, as well as minimal weight gain. Over 3000 patients have participated in clinical trials of asenapine, and the FDA accepted the manufacturer's NDA on November 26, 2007 for standard review. Some American psychiatrists have begun to prescribe the drug to combat veterans with severe PTSD nightmares as an "off-label" use, although it is not covered under the VA benefits package as of August 2012. Wikipedia [ - ]

Add type

Metaweb System Types

Object

Common

Topic

Medicine

Drug
Medical Treatment
Drug ingredient

Freebase

Object profile

Schema staging

Context name
Drug extra

Object is not asserted on this topic.

ID /type/object/id

-

GUID /type/object/guid

#9202a8c04000641f80000000046241ea

Type /type/object/type

Name /type/object/name

- - Edit
  - Delete
Asenapine

6 values total »

Key /type/object/key

Timestamp /type/object/timestamp

Tuesday, April 10, 2007 7:56 PM

Permission /type/object/permission

/boot/all_permission

Creator /type/object/creator

tristan

Attribution /type/object/attribution

tristan

Search /type/object/search

-

Machine ID /type/object/mid

/m/0264jhb

Also known as /common/topic/alias

-

Description /common/topic/description

- - Edit
  - Delete
Asenapine is an atypical antipsychotic developed for the treatment of schizophrenia and acute mania associated with bipolar disorder by Schering-Plough after its November 19, 2007 merger with Organon International. Development of the drug, through Phase III trials, began while Organon was still a part of Akzo Nobel. Preliminary data indicate that it has minimal anticholinergic and cardiovascular side effects, as well as minimal weight gain. Over 3000 patients have participated in clinical trials of asenapine, and the FDA accepted the manufacturer's NDA on November 26, 2007 for standard review. Some American psychiatrists have begun to prescribe the drug to combat veterans with severe PTSD nightmares as an "off-label" use, although it is not covered under the VA benefits package as of August 2012. Wikipedia

6 values total »

Image /common/topic/image

Official website /common/topic/official_website

-

Topic equivalent webpage /common/topic/topic_equivalent_webpage

12 values total »

Social media presence /common/topic/social_media_presence

-

Topical webpage /common/topic/topical_webpage

-

Subjects /common/topic/subjects

-

Subject of /common/topic/subject_of

-

Web Link(s) (deprecated) /common/topic/webpage

-

Properties /common/topic/properties

-

Article /common/topic/article

Asenapine (INN, trade names Saphris, Sycrest) is a new atypical antipsychotic developed for the...

Weblink /common/topic/weblink

-

Notable for /common/topic/notable_for

Drug

Notable types /common/topic/notable_types

Pronunciation (deprecated) /medicine/drug/pronunciation

-

ATC Code /medicine/drug/atccode

-

Drugbank /medicine/drug/drugbank

-

Pubchem (deprecated) /medicine/drug/pubchem

-

CAS Number (deprecated) /medicine/drug/cas_number

-

Pharmacological class /medicine/drug/drug_class

Atypical antipsychotic

Brands (deprecated) /medicine/drug/brands

-

Route of administration (deprecated) /medicine/drug/route_of_administration

-

Pregnancy category /medicine/drug/pregnancy_category

Pregnancy Category C (FDA)

Legal status /medicine/drug/legal_status

Prescription drug

ATC Code (deprecated) /medicine/drug/atc_code

-

Physiologic effect /medicine/drug/physiologic_effect

-

Mechanism of action /medicine/drug/mechanism_of_action

-

Marketed formulations /medicine/drug/marketed_formulations

Active moieties /medicine/drug/active_moieties

Asenapine

Active moiety of (deprecated) /medicine/drug/active_moiety_of

-

Part of compound drug (deprecated) /medicine/drug/part_of_compound_drug

-

Canonical brands /medicine/drug/canonical_brands

Saphris

Side effects /medicine/medical_treatment/side_effects

-

Contraindications /medicine/medical_treatment/contraindications

-

Trials /medicine/medical_treatment/trials

-

Used To Treat /medicine/medical_treatment/used_to_treat

Bipolar disorder

Active ingredient of formulation /medicine/drug_ingredient/active_ingredient_of_formulation

-

Active moiety of formulation /medicine/drug_ingredient/active_moiety_of_formulation

Active moiety of drug /medicine/drug_ingredient/active_moiety_of_drug

More general ingredient /medicine/drug_ingredient/more_general_ingredient

-

More specific ingredient /medicine/drug_ingredient/more_specific_ingredient

Asenapine maleate

Object profile is not asserted on this topic. Assert type now.

Object generation time /freebase/object_profile/object_generation_time

- - Edit
  - Delete
Saturday, May 25, 2013 8:31 AM

Link count /freebase/object_profile/link_count

-

Pronunciation /base/schemastaging/context_name/pronunciation

IPA	Yomigana	Pinyin	Zhuyin	Text	Value of property
-

Nickname /base/schemastaging/context_name/nickname

-

Official name /base/schemastaging/context_name/official_name

-

Former name /base/schemastaging/context_name/former_name

-

Abbreviation /base/schemastaging/context_name/abbreviation

-

Culinary /base/schemastaging/context_name/culinary

-

Medical /base/schemastaging/context_name/medical

-

Chemistry /base/schemastaging/context_name/chemistry

-

Biology /base/schemastaging/context_name/biology

-

Short name /base/schemastaging/context_name/short_name

-

Original name /base/schemastaging/context_name/original_name

-

Sports /base/schemastaging/context_name/sports

-

Disputed name preferred form /base/schemastaging/context_name/disputed_name_preferred_form

-

Regional variants /base/schemastaging/context_name/regional_variants

Variant name	Preferred in regions
-

Common name /base/schemastaging/context_name/common_name

- - Edit
  - Delete
Saphris

Pseudonym /base/schemastaging/context_name/pseudonym

-

Plural /base/schemastaging/context_name/plural

-

Comments

Hide